Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

A Simple Knock-In System for Xenopus via Microhomology Mediated End Joining Repair.

Suzuki KT, Sakane Y, Suzuki M, Yamamoto T.

Methods Mol Biol. 2018;1865:91-103. doi: 10.1007/978-1-4939-8784-9_7.

PMID:
30151761
2.

Live imaging analysis of the growth plate in a murine long bone explanted culture system.

Hirota K, Yasoda A, Kanai Y, Ueda Y, Yamauchi I, Yamashita T, Sakane Y, Fujii T, Inagaki N.

Sci Rep. 2018 Jul 9;8(1):10332. doi: 10.1038/s41598-018-28742-x.

3.

Rats deficient C-type natriuretic peptide suffer from impaired skeletal growth without early death.

Fujii T, Hirota K, Yasoda A, Takizawa A, Morozumi N, Nakamura R, Yotsumoto T, Kondo E, Yamashita Y, Sakane Y, Kanai Y, Ueda Y, Yamauchi I, Yamanaka S, Nakao K, Kuwahara K, Jindo T, Furuya M, Mashimo T, Inagaki N, Serikawa T, Nakao K.

PLoS One. 2018 Mar 22;13(3):e0194812. doi: 10.1371/journal.pone.0194812. eCollection 2018.

4.

Functional analysis of thyroid hormone receptor beta in Xenopus tropicalis founders using CRISPR-Cas.

Sakane Y, Iida M, Hasebe T, Fujii S, Buchholz DR, Ishizuya-Oka A, Yamamoto T, Suzuki KT.

Biol Open. 2018 Jan 22;7(1). pii: bio030338. doi: 10.1242/bio.030338.

5.

Effects of growth hormone on thyroid function are mediated by type 2 iodothyronine deiodinase in humans.

Yamauchi I, Sakane Y, Yamashita T, Hirota K, Ueda Y, Kanai Y, Yamashita Y, Kondo E, Fujii T, Taura D, Sone M, Yasoda A, Inagaki N.

Endocrine. 2018 Feb;59(2):353-363. doi: 10.1007/s12020-017-1495-y. Epub 2017 Dec 22.

PMID:
29274063
6.

Circulating osteocrin stimulates bone growth by limiting C-type natriuretic peptide clearance.

Kanai Y, Yasoda A, Mori KP, Watanabe-Takano H, Nagai-Okatani C, Yamashita Y, Hirota K, Ueda Y, Yamauchi I, Kondo E, Yamanaka S, Sakane Y, Nakao K, Fujii T, Yokoi H, Minamino N, Mukoyama M, Mochizuki N, Inagaki N.

J Clin Invest. 2017 Nov 1;127(11):4136-4147. doi: 10.1172/JCI94912. Epub 2017 Oct 9.

7.

A Simple Protocol for Loss-of-Function Analysis in Xenopus tropicalis Founders Using the CRISPR-Cas System.

Sakane Y, Suzuki KT, Yamamoto T.

Methods Mol Biol. 2017;1630:189-203. doi: 10.1007/978-1-4939-7128-2_16.

PMID:
28643260
8.

Regulation of type 1 iodothyronine deiodinase by LXRα.

Sakane Y, Kanamoto N, Yamauchi I, Tagami T, Morita Y, Miura M, Sone M, Yasoda A, Kimura T, Nakao K, Inagaki N.

PLoS One. 2017 Jun 15;12(6):e0179213. doi: 10.1371/journal.pone.0179213. eCollection 2017.

9.

Effect of Mandarin Orange Yogurt on Allergic Conjunctivitis Induced by Conjunctival Allergen Challenge.

Hara Y, Shiraishi A, Sakane Y, Takezawa Y, Kamao T, Ohashi Y, Yasunaga S, Sugahara T.

Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):2922-2929. doi: 10.1167/iovs.16-21206.

PMID:
28593244
10.

Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study.

Yamauchi I, Sakane Y, Fukuda Y, Fujii T, Taura D, Hirata M, Hirota K, Ueda Y, Kanai Y, Yamashita Y, Kondo E, Sone M, Yasoda A, Inagaki N.

Thyroid. 2017 Jul;27(7):894-901. doi: 10.1089/thy.2016.0562. Epub 2017 Jun 21.

PMID:
28537531
11.

In vivo confocal microscopic observations of eyes diagnosed with posterior corneal vesicles.

Shiraishi A, Zheng X, Sakane Y, Hara Y, Hayashi Y.

Jpn J Ophthalmol. 2016 Nov;60(6):425-432. Epub 2016 Sep 1.

PMID:
27585920
12.

Noninvasive Dry Eye Assessment Using High-Technology Ophthalmic Examination Devices.

Yamaguchi M, Sakane Y, Kamao T, Zheng X, Goto T, Shiraishi A, Ohashi Y.

Cornea. 2016 Nov;35 Suppl 1:S38-S48.

PMID:
27661073
13.

Visualization of Tear Clearance Using Anterior Segment Optical Coherence Tomography and Polymethylmethacrylate Particles.

Zheng X, Yamaguchi M, Kamao T, Sakane Y, Goto T, Shiraishi A, Ohashi Y.

Cornea. 2016 Nov;35 Suppl 1:S78-S82.

PMID:
27617874
14.

C-type natriuretic peptide restores impaired skeletal growth in a murine model of glucocorticoid-induced growth retardation.

Ueda Y, Yasoda A, Yamashita Y, Kanai Y, Hirota K, Yamauchi I, Kondo E, Sakane Y, Yamanaka S, Nakao K, Fujii T, Inagaki N.

Bone. 2016 Nov;92:157-167. doi: 10.1016/j.bone.2016.08.026. Epub 2016 Sep 2.

PMID:
27594049
15.

Rapid and efficient analysis of gene function using CRISPR-Cas9 in Xenopus tropicalis founders.

Shigeta M, Sakane Y, Iida M, Suzuki M, Kashiwagi K, Kashiwagi A, Fujii S, Yamamoto T, Suzuki KT.

Genes Cells. 2016 Jul;21(7):755-71. doi: 10.1111/gtc.12379. Epub 2016 May 24.

16.

In vivo tracking of histone H3 lysine 9 acetylation in Xenopus laevis during tail regeneration.

Suzuki M, Takagi C, Miura S, Sakane Y, Suzuki M, Sakuma T, Sakamoto N, Endo T, Kamei Y, Sato Y, Kimura H, Yamamoto T, Ueno N, Suzuki KT.

Genes Cells. 2016 Apr;21(4):358-69. doi: 10.1111/gtc.12349. Epub 2016 Feb 24.

17.

MMEJ-assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems.

Sakuma T, Nakade S, Sakane Y, Suzuki KT, Yamamoto T.

Nat Protoc. 2016 Jan;11(1):118-33. doi: 10.1038/nprot.2015.140. Epub 2015 Dec 17.

PMID:
26678082
18.

The Expression of TALEN before Fertilization Provides a Rapid Knock-Out Phenotype in Xenopus laevis Founder Embryos.

Miyamoto K, Suzuki KT, Suzuki M, Sakane Y, Sakuma T, Herberg S, Simeone A, Simpson D, Jullien J, Yamamoto T, Gurdon JB.

PLoS One. 2015 Nov 18;10(11):e0142946. doi: 10.1371/journal.pone.0142946. eCollection 2015.

19.

Homeolog-specific targeted mutagenesis in Xenopus laevis using TALENs.

Nakade S, Sakuma T, Sakane Y, Hara Y, Kurabayashi A, Kashiwagi K, Kashiwagi A, Yamamoto T, Obara M.

In Vitro Cell Dev Biol Anim. 2015 Oct;51(9):879-84. doi: 10.1007/s11626-015-9912-0. Epub 2015 Apr 29.

PMID:
25920501
20.

Involvement of Eyelid Pressure in Lid-Wiper Epitheliopathy.

Yamamoto Y, Shiraishi A, Sakane Y, Ohta K, Yamaguchi M, Ohashi Y.

Curr Eye Res. 2016;41(2):171-8. doi: 10.3109/02713683.2015.1009636. Epub 2015 Mar 24.

PMID:
25803436
21.

Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR/Cas9.

Nakade S, Tsubota T, Sakane Y, Kume S, Sakamoto N, Obara M, Daimon T, Sezutsu H, Yamamoto T, Sakuma T, Suzuki KT.

Nat Commun. 2014 Nov 20;5:5560. doi: 10.1038/ncomms6560.

22.

New method for viewing Krehbiel flow by polymethylmethacrylate particles suspended in fluorescein solution.

Yamaguchi M, Ohta K, Shiraishi A, Sakane Y, Zheng X, Kamao T, Yamamoto Y, Inoue Y, Ohashi Y.

Acta Ophthalmol. 2014 Dec;92(8):e676-80. doi: 10.1111/aos.12444. Epub 2014 Jun 2.

23.

Targeted mutagenesis of multiple and paralogous genes in Xenopus laevis using two pairs of transcription activator-like effector nucleases.

Sakane Y, Sakuma T, Kashiwagi K, Kashiwagi A, Yamamoto T, Suzuki KT.

Dev Growth Differ. 2014 Jan;56(1):108-14. doi: 10.1111/dgd.12105. Epub 2013 Dec 11.

PMID:
24329851
24.

Repeating pattern of non-RVD variations in DNA-binding modules enhances TALEN activity.

Sakuma T, Ochiai H, Kaneko T, Mashimo T, Tokumasu D, Sakane Y, Suzuki K, Miyamoto T, Sakamoto N, Matsuura S, Yamamoto T.

Sci Rep. 2013 Nov 29;3:3379. doi: 10.1038/srep03379.

25.

Conjunctivitis caused by Neisseria gonorrhoeae isolates with reduced cephalosporin susceptibility and multidrug resistance.

Suzuki T, Kitagawa Y, Maruyama Y, Yamaguchi S, Sakane Y, Miyamoto H, Ohashi Y.

J Clin Microbiol. 2013 Dec;51(12):4246-8. doi: 10.1128/JCM.01946-13. Epub 2013 Sep 11.

26.

New method for evaluation of early phase tear clearance by anterior segment optical coherence tomography.

Zheng X, Kamao T, Yamaguchi M, Sakane Y, Goto T, Inoue Y, Shiraishi A, Ohashi Y.

Acta Ophthalmol. 2014 Mar;92(2):e105-11. doi: 10.1111/aos.12260. Epub 2013 Sep 11.

27.

Development and validation of the Dry Eye-Related Quality-of-Life Score questionnaire.

Sakane Y, Yamaguchi M, Yokoi N, Uchino M, Dogru M, Oishi T, Ohashi Y, Ohashi Y.

JAMA Ophthalmol. 2013 Oct;131(10):1331-8. doi: 10.1001/jamaophthalmol.2013.4503.

PMID:
23949096
28.

[Evaluation of tear meniscus volume using the DR-1 tear specular scope].

Sakane Y, Yamaguchi M, Shiraishi A, Kataoka H, Ohashi Y.

Nippon Ganka Gakkai Zasshi. 2010 Jun;114(6):512-9. Japanese.

PMID:
20593656
29.

Determination of trace impurities in high-purity iron using salting-out of polyoxyethylene-type surfactants.

Matsumiya H, Sakane Y, Hiraide M.

Anal Chim Acta. 2009 Oct 19;653(1):86-90. doi: 10.1016/j.aca.2009.08.033. Epub 2009 Aug 27.

PMID:
19800478
30.

Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.

Monovich LG, Tommasi RA, Fujimoto RA, Blancuzzi V, Clark K, Cornell WD, Doti R, Doughty J, Fang J, Farley D, Fitt J, Ganu V, Goldberg R, Goldstein R, Lavoie S, Kulathila R, Macchia W, Parker DT, Melton R, O'Byrne E, Pastor G, Pellas T, Quadros E, Reel N, Roland DM, Sakane Y, Singh H, Skiles J, Somers J, Toscano K, Wigg A, Zhou S, Zhu L, Shieh WC, Xue S, McQuire LW.

J Med Chem. 2009 Jun 11;52(11):3523-38. doi: 10.1021/jm801394m.

PMID:
19422229
31.

Development of an assay suitable for high-throughput screening to measure matrix metalloprotease activity.

Peppard J, Pham Q, Clark A, Farley D, Sakane Y, Graves R, George J, Norey C.

Assay Drug Dev Technol. 2003 Jun;1(3):425-33.

PMID:
15090179
32.

Increased thrombopoietin levels in idiopathic thrombocytopenic purpura patients with a poor response to steroid therapy.

Sakane Y, Wada H, Kazuyo H, Shimura M, Nakasaki T, Katayama N, Nishikawa M, Deguchi K, Mori Y, Mori Y, Shiku H, Tahara T, Kato T.

Blood Coagul Fibrinolysis. 1998 Jun;9(4):315-21.

PMID:
9690802
33.

[Clinical test for early diagnosis of thrombosis].

Wada H, Sakane Y.

Nihon Naika Gakkai Zasshi. 1997 Jun 10;86(6):911-4. Japanese. No abstract available.

PMID:
9340356
34.
35.

New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11.

Fink CA, Qiao Y, Berry CJ, Sakane Y, Ghai RD, Trapani AJ.

J Med Chem. 1995 Dec 22;38(26):5023-30.

PMID:
8544178
36.

Dicarboxylic acid dipeptide neutral endopeptidase inhibitors.

Ksander GM, Ghai RD, deJesus R, Diefenbacher CG, Yuan A, Berry C, Sakane Y, Trapani A.

J Med Chem. 1995 May 12;38(10):1689-700.

PMID:
7752193
37.

A rapid indirect method to determine the plasma concentrations of neutral endopeptidase inhibitors.

Ghai RD, De Lombaert S, Ksander GM, Berry C, Sakane Y, Trapani AJ.

Res Commun Mol Pathol Pharmacol. 1995 Feb;87(2):211-20.

PMID:
7749658
38.
39.

N-Phosphonomethyl dipeptides and their phosphonate prodrugs, a new generation of neutral endopeptidase (NEP, EC 3.4.24.11) inhibitors.

De Lombaert S, Erion MD, Tan J, Blanchard L, el-Chehabi L, Ghai RD, Sakane Y, Berry C, Trapani AJ.

J Med Chem. 1994 Feb 18;37(4):498-511.

PMID:
8120868
40.

Heterocyclic lactam derivatives as dual angiotensin converting enzyme and neutral endopeptidase 24.11 inhibitors.

Stanton JL, Sperbeck DM, Trapani AJ, Cote D, Sakane Y, Berry CJ, Ghai RD.

J Med Chem. 1993 Nov 26;36(24):3829-33.

PMID:
8254612
41.

Design and synthesis of an orally active macrocyclic neutral endopeptidase 24.11 inhibitor.

MacPherson LJ, Bayburt EK, Capparelli MP, Bohacek RS, Clarke FH, Ghai RD, Sakane Y, Berry CJ, Peppard JV, Trapani AJ.

J Med Chem. 1993 Nov 26;36(24):3821-8.

PMID:
8254611
42.

Disposition of thiorphan in DOCA-salt and spontaneously hypertensive rats.

Sakane Y, Berry C, Hopkins MF, Singh K, Ghai RD.

Res Commun Chem Pathol Pharmacol. 1993 Aug;81(2):151-8.

PMID:
8210694
44.

The biological activity of atrial natriuretic factor cleaved by endoprotease 3.4.24.11.

Ghai RD, Webb RL, Sonnenberg JL, Sakane Y, Ghai G.

J Enzyme Inhib. 1991;4(3):267-72.

PMID:
1645400
45.

Carnitine metabolism and morphometric change of liver mitochondria in valproate-treated rats.

Murakami K, Sugimoto T, Nishida N, Woo M, Araki A, Kobayashi Y, Sakane Y.

Neuropediatrics. 1990 Nov;21(4):187-90.

PMID:
2290478
46.

Valproate-induced hepatoxicity: protective effect of L-carnitine supplementation.

Sugimoto T, Nishida N, Murakami K, Woo M, Sakane Y, Yasuhara A, Shuto H, Hatanaka T, Kobayashi Y.

Jpn J Psychiatry Neurol. 1990 Jun;44(2):387-8. No abstract available.

PMID:
2124297
47.

Enkephalinase inhibitors. 1. 2,4-Dibenzylglutaric acid derivatives.

Ksander GM, Diefenbacher CG, Yuan AM, Clark F, Sakane Y, Ghai RD.

J Med Chem. 1989 Dec;32(12):2519-26.

PMID:
2585440
48.

Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney.

Sonnenberg JL, Sakane Y, Jeng AY, Koehn JA, Ansell JA, Wennogle LP, Ghai RD.

Peptides. 1988 Jan-Feb;9(1):173-80.

PMID:
2966343
49.

Carnitine metabolism in valproate-treated rats: the effect of L-carnitine supplementation.

Nishida N, Sugimoto T, Araki A, Woo M, Sakane Y, Kobayashi Y.

Pediatr Res. 1987 Nov;22(5):500-3.

PMID:
3120144
50.

Degradation of atrial natriuretic factor by kidney cortex membranes. Isolation and characterization of the primary proteolytic product.

Koehn JA, Norman JA, Jones BN, LeSueur L, Sakane Y, Ghai RD.

J Biol Chem. 1987 Aug 25;262(24):11623-7.

Supplemental Content

Loading ...
Support Center